Cas:928007-64-1 Skinasensyl manufacturer & supplier

Chemical Name:Skinasensyl

CAS.NO:928007-64-1

Synonyms:N-Acetyl-L-tyrosyl-L-prolyl-L-phenylalanyl-L-phenylalaninamide;L-Phenylalaninamide, N-acetyl-L-tyrosyl-L-prolyl-L-phenylalanyl-;Acetyl tetrapeptide 15

Molecular Formula:C₃₄H₃₉N₅O₆

Molecular Weight:613.703

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:1055.3±65.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.617

PSA:

Exact Mass:613.290039

LogP:2.72

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-Acetyl-L-tyrosyl-L-prolyl-L-phenylalanyl-L-phenylalaninamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Acetyl tetrapeptide 15 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Acetyl-L-tyrosyl-L-prolyl-L-phenylalanyl-L-phenylalaninamide Use and application,Acetyl tetrapeptide 15 technical grade,usp/ep/jp grade.

Related News: In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. Skinasensyl manufacturer According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017). Skinasensyl supplier In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. Skinasensyl vendor In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. Skinasensyl factory According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017).